Join to View Full Profile
750 Washington StTuftsnemcBoston, MA 02111
Phone+1 617-636-0620
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Iris Jaffe, MD is a cardiologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts.
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 1999
- Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine
Certifications & Licensure
- MA State Medical License 2001 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Mineralocorticoid Receptor in Endothelial Cells Contributes to Vascular Endothelial Growth Factor Receptor Inhibitor-Induced Vascular and Kidney Damage.Nicholas D Camarda, Qing Lu, Angelina F Tesfu, Rui R Liu, Jaime Ibarrola
American Journal of Hypertension. 2025-01-16 - 1 citationsRapamycin Reduces Arterial Mineral Density and Promotes Beneficial Vascular Remodeling in a Murine Model of Severe Medial Arterial Calcification.Parya Behzadi, Rolando A Cuevas, Alex Crane, Andrew A Wendling, Claire C Chu
Biorxiv. 2024-12-22 - Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.Richard J Travers, Alec Stepanian, Iris Z Jaffe
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-10-01
Press Mentions
- Investigating Cancer Treatments’ Effects on the Heart and Blood VesselsDecember 14th, 2020
Grant Support
- Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular StiffnessTUFTS MEDICAL CENTER2014–2028
- Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular StiffnessTUFTS MEDICAL CENTER2014–2028
- Tufts BIRCWH ProgramTUFTS UNIVERSITY BOSTON2017–2027
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Supporting the Tufts BIRCWH Program with an Additional Scholar PositionTUFTS UNIVERSITY BOSTON2024–2025
- Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular ToxicityTUFTS MEDICAL CENTER2019–2025
- Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular ToxicityTUFTS MEDICAL CENTER2019–2025
- Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular ToxicityTUFTS MEDICAL CENTER2019–2025
- Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular ToxicityTUFTS MEDICAL CENTER2019–2025
- Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and HypertensionTUFTS MEDICAL CENTER2014–2025
- Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and HypertensionTUFTS MEDICAL CENTER2014–2025
- The Role of Vascular MR-Regulated Genes in Vascular Function and DiseaseTUFTS MEDICAL CENTER2009–2025
- Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapiesTUFTS MEDICAL CENTER2021–2024
